BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25873087)

  • 1. Analyses of 7,635 Patients with Colorectal Cancer Using Independent Training and Validation Cohorts Show That rs9929218 in CDH1 Is a Prognostic Marker of Survival.
    Smith CG; Fisher D; Harris R; Maughan TS; Phipps AI; Richman S; Seymour M; Tomlinson I; Rosmarin D; Kerr D; Chan AT; Peters U; Newcomb PA; Idziaszczyk S; West H; Meade A; Kaplan R; Cheadle JP
    Clin Cancer Res; 2015 Aug; 21(15):3453-61. PubMed ID: 25873087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of colorectal cancer-risk loci and survival outcome: A prognostic role for CDH1 variants.
    Summers MG; Maughan TS; Kaplan R; Law PJ; Houlston RS; Escott-Price V; Cheadle JP
    Eur J Cancer; 2020 Jan; 124():56-63. PubMed ID: 31734605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDH1 rs9929218 variant at 16q22.1 contributes to colorectal cancer susceptibility.
    Han P; Liu G; Lu X; Cao M; Yan Y; Zou J; Li X; Wang G
    Oncotarget; 2016 Jul; 7(30):47278-47286. PubMed ID: 27259261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation rs9929218 and risk of the colorectal Cancer and adenomas: A meta-analysis.
    Wang H; Gu D; Yu M; Hu Y; Chen Z; Huo X; Yu T; Chen J; Zheng Y
    BMC Cancer; 2021 Feb; 21(1):190. PubMed ID: 33627078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal cancer susceptibility loci and influence on survival.
    Song N; Kim K; Shin A; Park JW; Chang HJ; Shi J; Cai Q; Kim DY; Zheng W; Oh JH
    Genes Chromosomes Cancer; 2018 Dec; 57(12):630-637. PubMed ID: 30350386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide association study identifies tumor anatomical site-specific risk variants for colorectal cancer survival.
    Labadie JD; Savas S; Harrison TA; Banbury B; Huang Y; Buchanan DD; Campbell PT; Gallinger SJ; Giles GG; Gunter MJ; Hoffmeister M; Hsu L; Jenkins MA; Lin Y; Ogino S; Phipps AI; Slattery ML; Steinfelder RS; Sun W; Van Guelpen B; Hua X; Figuieredo JC; Pai RK; Nassir R; Qi L; Chan AT; Peters U; Newcomb PA
    Sci Rep; 2022 Jan; 12(1):127. PubMed ID: 34996992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic susceptibility variants associated with colorectal cancer prognosis.
    Abulí A; Lozano JJ; Rodríguez-Soler M; Jover R; Bessa X; Muñoz J; Esteban-Jurado C; Fernández-Rozadilla C; Carracedo A; Ruiz-Ponte C; Cubiella J; Balaguer F; Bujanda L; Reñé JM; Clofent J; Morillas JD; Nicolás-Pérez D; Xicola RM; Llor X; Piqué JM; Andreu M; Castells A; Castellví-Bel S;
    Carcinogenesis; 2013 Oct; 34(10):2286-91. PubMed ID: 23712746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between GWAS-identified genetic variations and disease prognosis for patients with colorectal cancer.
    Kang BW; Jeon HS; Chae YS; Lee SJ; Park JY; Choi JE; Park JS; Choi GS; Kim JG
    PLoS One; 2015; 10(3):e0119649. PubMed ID: 25799222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide Discovery and Identification of a Novel miRNA Signature for Recurrence Prediction in Stage II and III Colorectal Cancer.
    Kandimalla R; Gao F; Matsuyama T; Ishikawa T; Uetake H; Takahashi N; Yamada Y; Becerra C; Kopetz S; Wang X; Goel A
    Clin Cancer Res; 2018 Aug; 24(16):3867-3877. PubMed ID: 29514841
    [No Abstract]   [Full Text] [Related]  

  • 10. ADH1B and CDH1 polymorphisms predict prognosis in male patients with non-metastatic laryngeal cancer.
    Li D; Zhang R; Jin T; He N; Ren L; Zhang Z; Zhang Q; Xu R; Tao H; Zeng G; Gao J
    Oncotarget; 2016 Nov; 7(45):73216-73228. PubMed ID: 27689323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of cyclin D1 (CCND1) and E-cadherin (CDH1) alterations to colorectal cancer susceptibility: a case-control study.
    Govatati S; Singamsetty GK; Nallabelli N; Malempati S; Rao PS; Madamchetty VK; Govatati S; Kanapuram R; Narayana N; Bhanoori M; Kassetty K; Nallanchakravarthula V
    Tumour Biol; 2014 Dec; 35(12):12059-67. PubMed ID: 25146682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility genetic variants associated with colorectal cancer risk correlate with cancer phenotype.
    Abulí A; Bessa X; González JR; Ruiz-Ponte C; Cáceres A; Muñoz J; Gonzalo V; Balaguer F; Fernández-Rozadilla C; González D; de Castro L; Clofent J; Bujanda L; Cubiella J; Reñé JM; Morillas JD; Lanas A; Rigau J; García AM; Latorre M; Saló J; Fernández Bañares F; Argüello L; Peña E; Vilella A; Riestra S; Carreño R; Paya A; Alenda C; Xicola RM; Doyle BJ; Jover R; Llor X; Carracedo A; Castells A; Castellví-Bel S; Andreu M;
    Gastroenterology; 2010 Sep; 139(3):788-96, 796.e1-6. PubMed ID: 20638935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Prognostic and Predictive Value of Soluble Type IV Collagen in Colorectal Cancer: A Retrospective Multicenter Study.
    Rolff HC; Christensen IJ; Vainer B; Svendsen LB; Eefsen RL; Wilhelmsen M; Lund IK; Høyer-Hansen G; Nielsen HJ; Illemann M;
    Clin Cancer Res; 2016 May; 22(10):2427-34. PubMed ID: 26673797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of clinicopathological features with E-cadherin (CDH1) gene-160 C>A promoter polymorphism in Turkish colorectal cancer patients.
    Bahadir A; Eral G; Budak M; Shimamoto F; Korpinar MA; Erdamar S; Tuncel H
    J Cancer Res Ther; 2019; 15(1):26-31. PubMed ID: 30880750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twist2 is a valuable prognostic biomarker for colorectal cancer.
    Yu H; Jin GZ; Liu K; Dong H; Yu H; Duan JC; Li Z; Dong W; Cong WM; Yang JH
    World J Gastroenterol; 2013 Apr; 19(15):2404-11. PubMed ID: 23613636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A genome-wide search for determinants of survival in 1926 patients with advanced colorectal cancer with follow-up in over 22,000 patients.
    Wills C; He Y; Summers MG; Lin Y; Phipps AI; Watts K; Law PJ; Al-Tassan NA; Maughan TS; Kaplan R; Houlston RS; Peters U; Newcomb PA; Chan AT; Buchanan DD; Gallinger S; Marchand LL; Pai RK; Shi Q; Alberts SR; Gray V; West HD; Escott-Price V; Dunlop MG; Cheadle JP
    Eur J Cancer; 2021 Dec; 159():247-258. PubMed ID: 34794066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CDH1-160C>A polymorphism is a risk factor for colorectal cancer.
    Pittman AM; Twiss P; Broderick P; Lubbe S; Chandler I; Penegar S; Houlston RS
    Int J Cancer; 2009 Oct; 125(7):1622-5. PubMed ID: 19569232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short article: Influence of regulatory NLRC5 variants on colorectal cancer survival and 5-fluorouracil-based chemotherapy.
    Catalano C; da Silva Filho MI; Jiraskova K; Vymetalkova V; Levy M; Liska V; Vycital O; Naccarati A; Vodickova L; Hemminki K; Vodicka P; Weber ANR; Försti A
    Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):838-842. PubMed ID: 29762254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A let-7 microRNA SNP in the KRAS 3'UTR is prognostic in early-stage colorectal cancer.
    Smits KM; Paranjape T; Nallur S; Wouters KA; Weijenberg MP; Schouten LJ; van den Brandt PA; Bosman FT; Weidhaas JB; van Engeland M
    Clin Cancer Res; 2011 Dec; 17(24):7723-31. PubMed ID: 21994416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional polymorphisms of ATP citrate lyase gene predicts clinical outcome of patients with advanced colorectal cancer.
    Xie S; Zhou F; Wang J; Cao H; Chen Y; Liu X; Zhang Z; Dai J; He X
    World J Surg Oncol; 2015 Feb; 13():42. PubMed ID: 25890184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.